Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs Post published:August 19, 2021 Post category:Press Release
Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion Post published:August 17, 2021 Post category:Press Release
Cybin Announces Additional Adelia Milestone Achievements Post published:August 12, 2021 Post category:Press Release
Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option Post published:August 3, 2021 Post category:Press Release
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares Post published:July 28, 2021 Post category:Press Release
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5 Post published:July 28, 2021 Post category:Press Release
Cybin Announces Conditional Listing Approval from NYSE American Post published:July 22, 2021 Post category:Press Release
Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy Post published:July 13, 2021 Post category:Press Release
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio Post published:July 8, 2021 Post category:Press Release
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence Post published:July 6, 2021 Post category:Press Release